Gastrointestinal Endoscopy Devices – Market Insights – Japan

The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging population that is contributing to cases of GI-related diseases. However, despite these positive trends, factors such as ASP declines and lack of product innovation in some market segments will somewhat limit the market’s overall growth trajectory.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Japan from 2019 to 2034.

Nationwide CRC and GI cancer screening programs, along with supportive clinical guidelines, have contributed to the market’s growth.

How is the increasing prevalence of gastric cancer expected to shape demand trends for endoscopic devices over the forecast period?

Which GI endoscopic procedures and device segments are expected to experience the greatest shifts in demand?

The incorporation of AI has observed significant traction in this space.

What AI-integrated GI videoscope systems are presently on the market in Japan, and who are the leading manufacturers?

In what ways will the integration of AI into diagnostic tools reshape the market, and how might this shift affect competitive dynamics?

Which product segments will be affected the most over the forecast period?

The Japanese GI endoscopy market is saturated, with little room for growth in the majority of segments.

Which segments present growth opportunities within this market?

What benefits do local companies have compared to foreign competitors?

The capsule endoscope market will experience the most significant growth among the segments within the GI endoscopy device market.

What supports the strong growth of the capsule endoscope segment?

Who are the top players in this segment, and why?

What are the competitive strategies observed in this segment?